SCHEMBL6204551

SCHEMBL6204551

COc1cccc(CC([O])OC)c1

nearest known ligand 0.64

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.64
IDO1 P14902 2/20 0.51
AGXT P21549 2/20 0.51
CMA1 P23946 1/20 0.51
ALDH1A1 P00352 1/20 0.49
HTT P42858 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
MMP13 P45452 1/20 0.49
CHRM2 P08172 2/20 0.49
CHRM1 P11229 1/20 0.49
CHRM3 P20309 1/20 0.49
MTNR1A P48039 1/20 0.48
MTNR1B P49286 1/20 0.48
LMNA P02545 1/20 0.47
HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7450409 0.83 TAAR1 (0.70) TAAR1IDO1AGXTCMA1CHRM2
SCHEMBL17330016 0.81 TAAR1 (0.68) TAAR1IDO1AGXTCMA1CHRM2
SCHEMBL3163360 0.80 TAAR1 (0.71) TAAR1IDO1AGXTCMA1ALDH1A1
SCHEMBL6205345 0.80 IDO1 (0.47) TAAR1IDO1ALDH1A1
SCHEMBL449889 0.79 TAAR1 (0.76) TAAR1IDO1AGXTCMA1CHRM2
SCHEMBL10501393 0.79 TAAR1 (0.64) TAAR1IDO1AGXTCMA1ALDH1A1
SCHEMBL6204552 0.79 TAAR1 (0.64) TAAR1IDO1AGXTCMA1CHRM2
SCHEMBL151945 0.79 TAAR1 (0.74) TAAR1IDO1AGXTCMA1CHRM2
SCHEMBL6204382 0.79 SLC1A1 (0.46) TAAR1IDO1AGXT
SCHEMBL6203635 0.79 PNMT (0.58) TAAR1IDO1AGXTCHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed